FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to a pharmaceutical composition for treating eye infections caused by methicillin-resistant strains of Staphylococcus aureus, containing as an active substance the N-terminal CHAR endolysin of bacteriophage K Staphylococcus aureus.
EFFECT: declared pharmaceutical composition is non-toxic and more effective than the vancomycin antibiotic and extends the range of products for treating eye infections caused by methicillin-resistant Staphylococcus aureus strains.
1 cl, 7 ex, 1 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST BACTERIA PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, SALMONELLA TYPHI AND STAPHYLOCOCCUS HAEMOLYTICUS (EMBODIMENTS) | 2019 |
|
RU2730613C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST BACTERIA PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, SALMONELLA TYPHI AND STAPHYLOCOCCUS HAEMOLYTICUS (EMBODIMENTS) | 2019 |
|
RU2730614C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST GRAM-NEGATIVE BACTERIA: PSEUDOMONAS AERUGINOSA, ACINETOBACTER BAUMANNII, KLEBSIELLA PNEUMONIAE AND SALMONELLA TYPHI (EMBODIMENTS) | 2019 |
|
RU2730615C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS AN ANTIMICROBIAL AGENT DIRECTED AGAINST ACINETOBACTER BAUMANNII BACTERIA, (EMBODIMENTS) | 2019 |
|
RU2730616C1 |
| MODIFIED ENDOLYSIN AND ANTIBACTERIAL COMPOSITIONS BASED THEREON FOR TREATING INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII, PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI BACTERIA | 2023 |
|
RU2813626C1 |
| BACTERICIDAL PHARMACEUTICAL COMPOSITION FOR PARENTERAL USE IN THE FORM OF LYOPHILIZATE WITH ENDOLYSIN | 2021 |
|
RU2792679C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE INFECTIONS P. Aeruginosa CONTAINING RECOMBINANT LYSOZYME | 2011 |
|
RU2548803C2 |
| METHOD OF EXTRACTING VIRULENT BACTERIOPHAGES STAPHYLOCOCCUS AUREUS | 2020 |
|
RU2738743C1 |
| RECOMBINANT PLASMID DNA pQE-70_LysAP46 PROVIDING SYNTHESIS OF RECOMBINANT PROTEIN LysAP46, STRAIN OF ESCHERICHIA COLI BACTERIA - PRODUCER OF RECOMBINANT PROTEIN LysAP46 AND RECOMBINANT PROTEIN LysAP46, WHICH HAS ANTIBACTERIAL EFFECT | 2022 |
|
RU2809842C1 |
| METHOD FOR MICRO-DILUTION IN LIQUID MEDIUM FOR EVALUATING AND DETERMINING MINIMUM INHIBITORY CONCENTRATION OF ANTIBACTERIAL POLYPEPTIDES | 2017 |
|
RU2754667C2 |
